Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019

By Ju-Lan Hu, Runjiang Ke, Wilhem M. S. Teixeira, Yimin Dong, R. Ding, Jincui Yang, Xing Ai, Daqian Ye, Jiwen Shang. American Society of Nephrology. Clinical Journal, 2022

1,993 citations recorded by the source corpus.

Visual Abstract Background CKD is becoming a major human health concern. Limited quantitative assessments of the burden of CKD due to glomerulonephritis have been performed. We performed a comprehensive analysis of the disease burden to update the epidemiology of this disease. Methods Incidence, prevalence, deaths, and disability-adjusted life-years (DALYs) data and percent changes in these indicators were extracted from Global Burden of Disease Study 2019 to analyze the burden of CKD due to glomerulonephritis. Results Globally, there were 606,300 (95% uncertainty interval [UI], 560,100 to 658,100) incident patients, 17,300,000 (95% UI, 16,100,000 to 18,600,000) prevalent patients, 183,700 (95% UI, 146,300 to 228,900) deaths, and 6,900,000 (95% UI, 5,900,000 to 8,100,000) DALYs of CKD due to glomerulonephritis in 2019. Compared with those in 1990, the numbers of incident patients, prevalent patients, deaths, and DALYs increased by 77%, 81%, 100%, and 66%, respectively. Most of the disease burden was concentrated in countries with lower sociodemographic index. In Central Latin America, the disease burden was much higher than expected on the basis of its sociodemographic index. Decomposition analysis showed that population aging and growth were the two major drivers of the increase in DALYs. Frontier analysis revealed considerable opportunities to reduce the age-standardized DALYs in the middle of the sociodemographic-index spectrum. Although middle-aged and elderly individuals accounted for the majority of the disease burden, the highest incidence rate was observed in children aged 1–4 years. Conclusions The disease burden of CKD due to glomerulonephritis has increased worldwide, especially in regions and countries with lower sociodemographic indexes.

Subfields: Nephrology

View Paper: https://www.semanticscholar.org/paper/df9b2d432cc3735927d9eb44aec214c07fd4f240

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Shugang Qin
Min Wu
Huiqi Nong
Ze-jin Ou
Wen Xiao
Qian Zheng
Danfeng Yu
Shihao Tang

Citations in the corpus

mRNA-based therapeutics: powerful and versatile tools to combat diseases (2022, background): “mRNA vaccine candidates have shown similar safety and reactogenicity profiles to inactivated vaccines approved by the European Union and Americans, but acute and chronic infections account for 15% of all deaths worldwide due to unreasonable vaccine distribution in resourcelimited areas and insuffici”
Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019 (2021, result): “The judgments of trends were the follows: (1) an increasing trend of ASR was found when both the EAPC value and its 95% CI > 0; (2) a decreasing trend of ASR was found when both the EAPC value and 95% CI < 0; and (3) any other trends meant the ASR was stable over time.”